home / stock / dmttf / dmttf news

DMTTF News and Press, Small Pharma From 03/09/22

Stock Information
Company Name: Small Pharma
Stock Symbol: DMTTF
Market: OTC
Website: smallpharma.com
Menu
DMTTF DMTTF Quote DMTTF Short DMTTF News DMTTF Articles DMTTF Message Board
Get DMTTF Alerts

News, Short Squeeze, Breakout and More Instantly...
DMTTF - Small Pharma to Participate in the 34th Annual Roth Conference

LONDON, March 09, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuroscience company focused on psychedelic-assisted therapies for mental health conditions, announces its participation in th...
DMTTF - World's First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I

In the Phase I clinical trial, participants were administered SPL026 and underwent a 20-minute psychedelic experience Phase I full dataset demonstrates consistent dose related effects on the intensity and quality of the psychedelic experience LONDON, Feb. 22, 2022 (GLOBE N...

DMTTF - Small Pharma Reports Fiscal Third Quarter 2021 Highlights

LONDON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted N,N-dimethyltryptamine (“ DMT ”) therapies, has t...

DMTTF - Small Pharma to Attend Upcoming Healthcare Conferences in January 2022

LONDON, United Kingdom, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce its attendance at...
DMTTF - Small Pharma to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6, 2021

LONDON, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces its participation in the H.C. Wainwright 2...

DMTTF - Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

LONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces that Mr. Paul Maier has been appointed as a no...

DMTTF - Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder

LONDON, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted therapies today confirms, following positive discussions with the U...
DMTTF - Small Pharma to Attend Upcoming Healthcare Conferences in November 2021

LONDON, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce its attendance at the LSX Inv...

DMTTF - Small Pharma reports FQ2 results

Small Pharma (OTCPK:DMTTF): FQ2 GAAP EPS of -C$0.01. Press Release For further details see: Small Pharma reports FQ2 results

DMTTF - Small Pharma Reports Second Quarter Highlights

Company advances ongoing clinical trials with Phase I completed and dosing initiated in Phase IIa trial for lead product candidate, SPL026, a DMT-assisted therapy for the treatment of Major Depressive Disorder Fast-track Innovation Passport Designation awarded by the MHRA ...
Previous 10 Next 10